| Net loss | -24.31M |
| Depreciation and amortization | |
| Stock-based compensation expense | 2.03M |
| Amortization of intangible assets and acquired technology | 239K |
| Gain on sale of marketable securities | |
| Accounts receivable, net | 3.08M |
| Inventory | -27K |
| Prepaid expenses and other assets | 1.44M |
| Accounts payable and accrued liabilities | 2.38M |
| Net cash provided by (used in) operating activities | -12.51M |
| Purchases of property and equipment | -2.86M |
| Maturities and sales of investments | 2.42M |
| Net cash provided by investing activities | -441K |
| Net proceeds from issuances of common stock and exercise of stock options | |
| Net increase in cash and cash equivalents | 2.76M |
| Cash and cash equivalents at beginning of period | 13.27M |
| Cash and cash equivalents at end of period | 16.03M |